Tumour-Specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens-Reference-Cited by-同舟云学术

Tumour-Specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens

Published:1993-08 Issue:4 Volume:71 Page:311-326
ISSN:0818-9641
Container-title:Immunology and Cell Biology
language:en
Short-container-title:

Author:

SCHIRRMACHER VOLKER,SCHILD HANS-JÖRG,GÜCKEL BRIGITTE,VON HOEGEN PAUL

Publisher

Wiley

Subject

Cell Biology,Immunology,Immunology and Allergy

Link

http://www.nature.com/articles/icb199336.pdf

Reference34 articles.

1. Cytokines and Cancer: Experimental systems;Blankenstein;Curr. Opin. Immunol.,1991

2. Cancer vaccines show promise at last;Marx;Science,1989

3. Viral oncolysates as human tumor vaccines;Sinkovics;Intern. Rev. Immunol.,1991

4. Immunobiology and immunotherapy of cancer metastases: Ten year studies in an animal model resulting in the design of an immunotherapy procedure now under clinical testing;Schirrmacher;Interdisciplinary Science Reviews,1989

5. In situ activation of syngeneic tumor specific cytotoxic T-lymphocytes: Importance of site of antigen stimulation;Schirrmacher;Cancer Immunol. Immunother.,1991

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen presentation in cancer — mechanisms and clinical implications for immunotherapy;Nature Reviews Clinical Oncology;2023-06-16

2. Multi-antigen spherical nucleic acid cancer vaccines;Nature Biomedical Engineering;2023-01-30

3. Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy;Theranostics;2022

4. CD4 and CD8 T lymphocyte interplay in controlling tumor growth;Cellular and Molecular Life Sciences;2017-10-14

5. Oncolytic Newcastle disease virus as a prospective anti-cancer therapy. A biologic agent with potential to break therapy resistance;Expert Opinion on Biological Therapy;2015-10-05